glp 1 agonist overdose GLP-1 overdoses have been skyrocketing, with poison centers seeing a nearly 1500% increase in calls related to or side effects of injectable weight-loss drugs since 2019, according to US National Poison Frontiers | Pharmacovigilance study of

Schaevitz et al., 2014)

The new drug targets a group of proteins in the body known as ERRs, which are responsible for activating some of the most important metabolic pathways in energy-gobbling tissues like muscles, the heart, and the brain

[DOI] [PubMed] [Google Scholar] 65.Veal E., Day A

Clinical Monitoring May Be Required: Patients with fluid retention or renal impairment , such as those with congestive heart failure or pulmonary edema Electrolyte and acid-base balance should be monitored during administration May interact with some medications (e.g., corticosteroids, corticotropin) Important Note: Sodium Chloride Injection must be used once and discarded

Every batch is individually identified to support scientific research, product traceability and laboratory record keeping

476 The study results suggest that semaglutide may be a more suitable choice for patients with severe insulin deficiency, while dapagliflozin might be effective for a broader range of patients with metabolic abnormalities